Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCoV-19) vaccine: report of two cases
Vaccination with ChAdOx1 nCoV-19 can result in vaccine-induced immune thrombotic thrombocytopenia (VITT). This phenomenon mimics heparin-induced thrombocytopenia, yet it does not require heparin as a trigger. This case report highlights the potentially lifethreatening complication associated with C...
Main Authors: | Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2022-05-01
|
Series: | Bleeding, Thrombosis and Vascular Biology |
Subjects: | |
Online Access: | https://btvb.org/btvb/article/view/23 |
Similar Items
-
Vaccine‐induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine–A case report
by: Bader Al Rawahi, et al.
Published: (2021-08-01) -
Alopecia areata following ChAdOx1 nCoV-19 vaccination (Oxford/AstraZeneca)
by: Hsuan-An Su, et al.
Published: (2022-10-01) -
Impact of Improper Storage of ChAdOx1-S (AstraZeneca) Vaccine on Its Efficacy and Safety
by: Marek Mikołajczyk, et al.
Published: (2022-12-01) -
Psoriatic flare following Oxford-AstraZeneca ChAdOx1 COVID-19 and influenza vaccines
by: Natalie Teh, et al.
Published: (2021-12-01) -
Malaysia to use AstraZeneca vaccine
by: Povera, Adib
Published: (2021)